Showing results (181-190 of 213) with videos related to

Sort By:
Pageof 22
American Journal of Nuclear Medicine and Molecular Imaging|December 5, 2018
A dual-labeled cRGD-based PET/optical tracer for pre-operative staging and intraoperative treatment of colorectal cancerBabs G Sibinga Mulder, Henricus Jm Handgraaf, Danielle J Vugts, et al.
Oncotarget|August 27, 2015
89Zr-cetuximab PET imaging in patients with advanced colorectal cancerCatharina Willemien Menke-van der Houven van Oordt, Elske C Gootjes, Marc C Huisman, et al.
Advanced Materials (Deerfield Beach, Fla.)|April 15, 2022
PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in PatientsIris H C Miedema, Gerben J C Zwezerijnen, Marc C Huisman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2019
Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid TumorsC Willemien Menke-van der Houven van Oordt, Adam McGeoch, Mats Bergstrom, et al.
Bioconjugate Chemistry|April 9, 2021
Synthesis and Comparative In Vivo Evaluation of Site-Specifically Labeled Radioimmunoconjugates for DLL3-Targeted ImmunoPETSai Kiran Sharma, Pierre Adumeau, Outi Keinänen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2021
ImmunoPET of Ovarian and Pancreatic Cancer with AR9.6, a Novel MUC16-Targeted Therapeutic AntibodySai Kiran Sharma, Kyeara N Mack, Alessandra Piersigilli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2019
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man studyMarloes H J Hagens, Sandeep S V Golla, Bieneke Janssen, et al.
EJNMMI Research|February 16, 2024
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptorAntonia A Högnäsbacka, Alex J Poot, Christophe Plisson, et al.
EJNMMI Research|May 23, 2019
The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humansKevin S Thorneloe, Armin Sepp, Sean Zhang, et al.
Molecular Pharmaceutics|December 15, 2018
F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational ApproachStefan T G Bruijnen, Durga M S H Chandrupatla, Leonardo Giovanonni, et al.
Pageof 22